Visualizar Tese - Instituto de Biociências - Unesp

Cirilo, PDRREFERÊNCIAS213leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab, 89, 5549–5557,2004.Doridot V, This P, Clough KB. Explosive growth of uterine leiomyomas and carcinologic ovarian riskin a non-menopausal patient with BRCA1-BRCA2 mutation treated by tamoxifen. J GynecolObstet Biol Reprod, 31, 677-680, 2002.Douglas EJ, Fiegler H, Rowan A et al. Array comparative genomic hybridization analysis ofcolorectal cancer cell lines and primary carcinomas. Cancer Res, 64, 4817-4825, 2004.Duhan N and Sirohiwal D. Uterine myomas revisited. Eur J Obstet Gynecol Reprod Biol, 152, 119-125, 2010.Eifel P, Axelson JA, Costa J et al. National Institutes of Health consensus development conferencestatement: adjuvant therapy for breast cancer. J Natl Cancer Inst, 93, 979–989, 2001.El-Gharib MN and Elsobky ES. Cytogenetic aberrations and the development of uterineleiomyomata. J Obstet Gynaecol Res, 36, 101–107, 2010.Englund K, Lindblom B, Carlstrom K et al. Gene expression and tissue concentrations of IGF-I inhuman myometrium and fibroids under different hormonal conditions. Mol Hum Reprod, 6,915–920, 2000.Farquhar CM and Steiner CA. Hysterectomy rates in the United States 1990–1997. Obstet Gynecol,99, 229–34, 2002.FEBRASGO - Manual de Orientação – Leiomioma Uterino. Federação Brasileira das Sociedades deGinecologia e Obstetrícia, 117pp, 2004.Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. EnvironHealth Perspect, 111, 1037-1054, 2003.Floyd RV, Wray S, Quenby S et al. Expression and distribution of Na, K-ATPase isoforms in thehuman uterus. Reprod Sci, 17, 366-376, 2010.Forbes SA, Pannett AA, Bassett JH et al. Mapping of the gene encoding the B56 beta subunit ofprotein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and itsexclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1). Hum Genet,100, 481-485, 1997.Fotiou SK, Tserkezoglou AJ, Mahera H et al. Chromosome aberrations and expression of ras and myconcogenes in leiomyomas and a leiomyosarcoma of the uterus. Eur J Gynaecol Oncol, 1, 340-345, 1992.Fusco A and Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer, 7, 899-910, 2007.Gajria D and Chandarlapaty S. HER2-amplified breast cancer: mechanisms of trastuzumabresistance and novel targeted therapies. Expert Rev Anticancer Ther, 11, 263-275, 2011.Galiègue-Zouitina S, Delestré L, Dupont C et al. Underexpression of RhoH in Hairy Cell LeukemiaCancer Res, 68, 4531-4540, 2008.